Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 569 | 256 | 0 | 10,000 | 0 |
| Cost of Goods | 341 | 154 | N/A | N/A | N/A |
| Gross Profit | 228 | 102 | N/A | 10,000 | N/A |
| Operating Expenses | 40,206 | 35,654 | 22,543 | 23,651 | 17,739 |
| Operating Income | -39,637 | -35,398 | -22,543 | -13,651 | -17,739 |
| Other Income | 52 | 109 | 129 | 121 | 71 |
| Pre-tax Income | -39,585 | -35,289 | -22,414 | -13,530 | -17,668 |
| Net Income Continuous | -40,285 | -35,289 | -22,414 | -13,530 | -17,668 |
| Net Income | $-40,285 | $-35,289 | $-22,414 | $-13,530 | $-17,668 |
| EPS Basic Total Ops | -0.46 | -0.38 | -0.24 | -0.15 | -0.22 |
| EPS Basic Continuous Ops | -0.44 | -0.38 | -0.24 | -0.15 | -0.22 |
| EPS Diluted Total Ops | -0.46 | -0.38 | -0.24 | -0.15 | -0.22 |
| EPS Diluted Continuous Ops | -0.44 | -0.38 | -0.24 | -0.15 | -0.22 |
| EBITDA(a) | $-39,516 | $-35,301 | $-22,487 | $-13,619 | $-17,719 |